Published

Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: CNS Neuroscience & Therapeutics
Date: 2023-03-01
Source: Crossref
DOI: 10.1111/cns.14054
PubMed: 36627756

Authors

Wang Jing Liang Min Shang Qing Qian Hongyan An Ran Liu Hua Shao Gaojie Li Tao Liu Xinshe

Watch author

Derived topics and classifications

psilocybin psilocin Mechanism of Action Receptor Pharmacology Animal Study Animal Study

Citation graph

40 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

10.1080/03602532.2016.1278228 10.1177/0269881108093587 10.1177/0269881116675513 10.1177/0269881114565144 10.1177/0269881114548296 10.1038/s41386-019-0324-9 10.1016/j.bbrc.2013.11.104 10.1016/j.bbamcr.2010.08.010 10.1016/s0893-133x(98)00108-0 10.1016/j.brainresrev.2009.03.002 10.1073/pnas.0610790104 10.1016/j.neuroscience.2009.03.060

Indexed papers citing this DOI

Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways2025-04-01 Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling2023-03-01

Related papers

No close related records were found yet.